NCT02628067 2025-09-22KEYNOTE 158Merck Sharp & Dohme LLCPhase 2 Active not recruiting1,609 enrolled 5 FDA
NCT07165132 2025-09-10Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.RayzeBio, Inc.Phase 1 Not yet recruiting104 enrolled
NCT04524442 2025-01-24Post-Authorization Safety Study (PASS) of LysaKare® in Adult Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) PatientsAdvanced Accelerator ApplicationsPhase 4 Completed42 enrolled 11 charts
NCT03817866 2022-12-20Chromogranin A as Blood Marker in Cancer PatientsBrahms AGCompleted175 enrolled
NCT00986661 2022-11-02A Study to Assess PV-10 Chemoablation of Cancer of the LiverProvectus PharmaceuticalsPhase 1 Unknown78 enrolled
NCT01327612 2021-02-21Open Label Extension Study of Conatumumab and Ganitumab (AMG 479)AmgenPhase 2 Completed12 enrolled 21 charts